Please log in to view this page
Username
Password
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
